| memantine / Generic mfg. |
NCT00234637: Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment |
|
|
| Completed | 4 | 204 | Europe | Rivastigmine, memantine | Novartis | Alzheimer's Disease | 06/05 | 06/05 | | |
NCT00855686: Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies |
|
|
| Completed | 4 | 199 | Europe | Memantine, Ebixa®, Placebo | H. Lundbeck A/S | Parkinson's Disease Dementia, Dementia With Lewy Bodies | 12/08 | 01/09 | | |
NCT00862940: A Clinical Study Evaluating the Effects of Memantine on Brain Atrophy in Patients With Alzheimer's Disease |
|
|
| Completed | 4 | 277 | Europe | Memantine, Ebixa®, Placebo | H. Lundbeck A/S | Alzheimer's Disease | 02/09 | 04/09 | | |
| Terminated | 4 | 19 | Europe | Memantine | Merz Pharmaceuticals GmbH | Alzheimer's Disease | 05/09 | 06/09 | | |
NCT00401167: Memantine for Agitation and Aggression in Severe Alzheimer's Disease |
|
|
| Completed | 4 | 31 | Canada | memantine | Sunnybrook Health Sciences Centre, Lundbeck Canada Inc. | Alzheimer's Disease | 01/10 | 01/10 | | |
NCT00800709: Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's Disease |
|
|
| Completed | 4 | 26 | RoW | Memantine, Memantine hydrochloride | Shanghai Mental Health Center, H. Lundbeck A/S | Alzheimer's Disease | 10/10 | 10/10 | | |
NCT02553928: Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer |
|
|
| Completed | 4 | 62 | RoW | Memantine (once daily), Lu 00-800, Ebixa ®, Ebix ®, Memantine (twice daily) | H. Lundbeck A/S | Alzheimer Dementia (AD) | 07/16 | 07/16 | | |
